These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 38139138)
1. Altered Phenotypes of Breast Epithelial × Breast Cancer Hybrids after ZEB1 Knock-Out. Merckens A; Sieler M; Keil S; Dittmar T Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139138 [TBL] [Abstract][Full Text] [Related]
2. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells. Gauck D; Keil S; Niggemann B; Zänker KS; Dittmar T BMC Cancer; 2017 Aug; 17(1):515. PubMed ID: 28768501 [TBL] [Abstract][Full Text] [Related]
3. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
4. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo. Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340 [TBL] [Abstract][Full Text] [Related]
5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
6. Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties. Fahlbusch SS; Keil S; Epplen JT; Zänker KS; Dittmar T BMC Cancer; 2020 May; 20(1):446. PubMed ID: 32430004 [TBL] [Abstract][Full Text] [Related]
7. Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma. Lien HC; Yu HC; Yu WH; Lin SF; Chen TW; Chen IC; Hsiao LP; Yeh LC; Li YC; Lo C; Lu YS Breast Cancer Res; 2024 Sep; 26(1):130. PubMed ID: 39256881 [TBL] [Abstract][Full Text] [Related]
8. Antcin-A Modulates Epithelial-to-Mesenchymal Transition and Inhibits Migratory and Invasive Potentials of Human Breast Cancer Cells via p53-Mediated miR-200c Activation. Kumar KJS; Vani MG; Hsieh HW; Lin CC; Wang SY Planta Med; 2019 Jul; 85(9-10):755-765. PubMed ID: 31185503 [TBL] [Abstract][Full Text] [Related]
9. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis. Shi D; Guo L; Sun X; Shang M; Meng D; Zhou X; Liu X; Zhao Y; Li J Sci Rep; 2020 Apr; 10(1):6657. PubMed ID: 32313093 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer. Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864 [TBL] [Abstract][Full Text] [Related]
11. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
12. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Kong X; Ding X; Li X; Gao S; Yang Q Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells. Wang M; Zhang R; Zhang S; Xu R; Yang Q Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1. Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477 [TBL] [Abstract][Full Text] [Related]
15. Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation. Zheng T; Han W; Wang A; Wang Y PeerJ; 2022; 10():e12802. PubMed ID: 35186455 [TBL] [Abstract][Full Text] [Related]
16. Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins. Lu H; Wu Z; Wang Y; Zhao D; Zhang B; Hong M Phytomedicine; 2022 Sep; 104():154291. PubMed ID: 35839735 [TBL] [Abstract][Full Text] [Related]
17. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells. Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391 [TBL] [Abstract][Full Text] [Related]
18. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer. Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360 [TBL] [Abstract][Full Text] [Related]
20. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]